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Background: Sub clinical hypothyroidism (SCH) is related to dyslipidemia and atherosclerosis. We explored the effect of SCH on cardiovascular 
mortality (CVM).
methods: We queried the NHANES-III database (n=7883). We excluded individuals <40 years, TSH levels ≥20 and ≤0.35mIU/L. We defined SCH 
as individuals with TSH levels between 5-19.99 mIU/L and T4 levels between 5-12 µg/dl. Individuals with TSH between 0.36-4.99 were considered 
euthyroid. We calculated unadjusted and adjusted hazard ratios over a mean period of 12.3 years.
results: Prevalence of SCH was 5.34%. In individuals with SCH, 25.18% had CVM versus 16.89% in the euthyroid group. SCH is a strong 
independent predictor of CVM and ischemic heart disease mortality. (log-rank test p-value<0.001)
conclusion: SCH predicts CVM in a healthy population.
